Interventional Cardiology Devices
Interventional cardiology devices consist of various non-surgical processes for the treatment of cardiovascular diseases. The cardiologists make use of various kinds of catheters to perforate the blood vessels to implement several diagnostic tests and/or to fix the damaged heart vessels. These types of devices are mainly used to treat the diseases related to the heart valves, peripheral vascular disease, and coronary artery disease. Also, these devices obviate the necessity of surgeries. On account of the less invasive nature of interventional cardiology, this surgical procedure renders benefits such as less number of days in the hospital, reduced cost, minimal incision, and faster recovery time.
Different segments of Interventional Cardiology Devices
Stents – It is a small mesh-like tube used to treat tapered or weak arteries. The method where a stent is placed in an artery is called Percutaneous Coronary Intervention (PCI), more commonly termed as coronary angioplasty. A few of the most commonly used stents are:
Catheters – They are hollow and sleek tubes which are inserted into a large blood vessel that leads to the heart. The procedure is also termed as cardiac catheterization and is done to determine if an individual has any diseases pertaining to the heart muscle, valves or coronary arteries. Types of catheters used in cardiology surgeries are:
PTCA Balloons – Percutaneous Transluminal Coronary Angioplasty Balloons (balloon angioplasty) is an endovascular process to broaden a narrowed and/or blocked veins or arteries. Balloons are normally used to treat arterial atherosclerosis. The method comprises of a deflated balloon which is bypassed into a narrow arterial location and then inflated to a fixed size. Various forms of balloons that are used in cardiology are:
Apart from the aforementioned, interventional cardiology devices are also used for cardiovascular imaging purposes such as intravascular ultrasound (IVUS), Fractional Flow Reserve (FFR), and Optical Coherence Tomography (OCT). This decline in the market’s demand is due to the decreasing percentage in the coronary angioplasty procedures. Presently, there a few key industry players who are trying gain lucrative market share by introducing bio-absorbable stents into the U.S market.